Filing Details
- Accession Number:
- 0000950170-24-119161
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-30 17:50:51
- Reporting Period:
- 2024-10-29
- Accepted Time:
- 2024-10-30 17:50:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
742112 | Invacare Holdings Corp | IVCRQ | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 384264819 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1591418 | Pm Manager Fund, Spc-Segregated Portfolio 33 | 66 Bovet Road, Suite 353 San Mateo CA 94402 | No | No | No | No | |
1633055 | Endurant Capital Management Lp | 66 Bovet Road, Suite 353 San Mateo CA 94402 | No | No | No | No | |
1977861 | Minh Quang Pham | 66 Bovet Road, Suite 353 San Mateo CA 94402 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Series B Redeemable Preferred Stock (Non-Convertible) | Acquisiton | 2024-10-29 | 2,431,075 | $0.00 | 2,431,075 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | 9.00% Series A Convertible Participating Preferred Stock | Disposition | 2024-10-29 | 2,431,075 | $0.00 | 39,900,220 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2023-11-06 | No | 4 | S | Indirect |
Footnotes
- Effective as of October 29, 2024, the Reporting Persons exchanged each share of 9.00% Series A Convertible Participating Preferred Stock of the Issuer (the "Series A Preferred Stock") then held by the Reporting Persons for (i) one share of nonconvertible Series B Redeemable Preferred Stock of the Issuer and (ii) an increase by approximately $26.41 of the principal amount due to the Reporting Persons and/or certain of their affiliates under the Issuer's Loan and Security Agreement, as amended.
- Shares reported herein are held by private investment funds, including PM Manager Fund, SPC-Segregated Portfolio 33 ("SP33"), and separately managed accounts for which Endurant Capital Management LP serves as the investment manager. Mr. Pham serves as the Managing Member of Endurant Capital Management LP. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein, and the filing of this Form 3 shall not be construed as an admission that either of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- The Series A Preferred Stock has no expiration date. Holders of shares of Series A Preferred Stock have the option to convert all or a portion of their shares of Series A Preferred Stock into common stock of the Issuer at a rate equal to the then liquidation preference of the Series A Preferred Stock (initially $25 per share) divided by $1.72076211. The Series A Preferred Stock contains automatic adjustment features to the liquidation preference including, among other things, an accruing payment-in-kind dividend feature.